Skip to main content
Log in

HIV-1-Antigenämie und T-Zell-Aktivierung bei HIV-1-infizierten Patienten

HIV-1-antigenemia and T-cell-activation in HIV-infected patients

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

In order to study a supposed association between T-cell activation in vivo and HIV-1-antigenemia in HIV-1-infected patients, the detection of p24-antigen in sera was correlated to serum levels of beta-2-microglobulin and C1q-binding immune complexes. Anti-p24-antibodies and the urinary excretion of neopterin were also analysed.

In 24 of 80 patients (30%) p24-antigen could be detected, and in 15 of 59 (25.4%) there was a loss of anti-p24-antibodies. Tests revealed elevated serum levels of beta-2-microglobulin in 58 of 80 patients (72.5%), elevated levels of C1q-binding immune complexes in 15 of 66 (22.7%), and increased excretion of neopterin in 52 of 60 (86.7%). Detection of p24-antigen, loss of antip24-antibodies, serum levels of beta-2-microglobulin, and urinary excretion of neopterin were significantly correlated to advanced stages of HIV-1 infection.

Patients with p24-antigen in the serum showed significantly more frequently elevated serum levels of beta-2-microglobulin and no significant association with increased urinary excretion of neopterin.

Because of the high proportion of patients with elevated serum levels of beta-2-microglobulin and increased excretion of urinary neopterin in the absence of detectable p24-antigen in serum, we could not correlate HIV-1-antigenemia to T-cell activation in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

AIDS:

Acquired Immunodeficiency Syndrome

CD:

Cluster of differentiation

HIV:

Human Immunodeficiency Virus

PHA:

Phythämagglutinin

WR:

Walter-Reed-Stadium

Literatur

  1. Burmester GR, Kalden JR (1983) Die immunologisch gesteuerte zelluläre Infektabwehr. Lab med 7:225–230

    Google Scholar 

  2. von Briesen H, Becker WB, Henco K, Helm EB, Gelderblom HR, Brede HD, Rübsamen-Waigmann H (1987) Isolation frequency and growth properties of HIV-variants. Multiple simultaneous variants in a patient demonstrated by molecular cloning. J med Virol 23:51–66

    Google Scholar 

  3. Fisher AG, Ensoli B, Looney D, Rose A, Gallo RC, Saag MS, Shaw GM, Hahn BH, Wong-Staal F (1988) Biologically diverse molecular variants within a single HIV-1 isolate. Nature 334:444–447

    Google Scholar 

  4. Goedert JJ, Eyster ME, Biggar RJ, Blattner WA (1987) Heterosexual transmission of Human Immunodeficiency Virus: association with severe depletion of T-helper lymphocytes in men with hemophilia. AIDS Res Human Retrovir 3:355

    Google Scholar 

  5. Grieco MH, Reddy MM, Kothary HB, Lange M, Buimovici-Klein E, William D (1984) Elevated beta-2-Mikroglobulin and lysozym levels in patients with the acquired immuno deficiency syndrome. Clin Immunol Immunopathol 32:174–184

    Google Scholar 

  6. Hahn BH, Shaw GM, Taylor ME, Redfield RR, Markham PD, Salahuddin SZ, Wong-Staal F, Gallo RC, Parks ES, Parks WP (1986) Genetic variations in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. Science 232:1548–1551

    Google Scholar 

  7. Harms V (1982) Biomathematik, Statistik und Dokumentation. 4. Auflage, Harms, Kiel

    Google Scholar 

  8. Harper ME, Marselle LM, Gallo RC, Wong-Staal F (1987) Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridisation. Proc Natl Acad Sci USA 83:772–776

    Google Scholar 

  9. Hausen A, Dierich MP, Fuchs D, Hengster P, Reibnegger G, Schulz T, Werner ER, Wachter H (1986) Immunosuppressants in patients with AIDS. Nature 320:114

    Google Scholar 

  10. Huber CH, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D, Reibnegger G, Sewtly P, Troppmair J, Wachter H (1984) Immune response-associated production of neopterin. J Exp Med 160:310–316

    Google Scholar 

  11. Kunze R, Jovaisas E, Falkenberg S, Marcus U, Bandmann J, Vettermann W, L'age-Stehr J, Koch M (1984) Ergebnisse klinischer und labormedizinischer Untersuchungen an homosexuellen Männern im Rahmen einer AIDS-Beratungsstelle. Bundesgesundhbl 27:242–247

    Google Scholar 

  12. McDougal JS, Mawle A, Cort SP, Nicholson JKA, Cross GD, Scheppler-Campbell JA, Hicks D, Sligh J (1985) Cellular tropism of the human retrovirus HTLV-III/LAV: I. Role of T-cell activation and expression of the T4 antigen. Journal of Immunology 135:3151–3162

    Google Scholar 

  13. Mosca JD, Bednarik DP, Raj NBK, Rosen CA, Sodroski JG, Haseltine WA, Pitha PM (1987) Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus. Nature 325:67–70

    Google Scholar 

  14. Morrow WJW, Wharton M, Stricker RB, Levy JA (1986) Circulating immune complexes in patients with acquired immune deficiency syndrome contain the AIDS-associated retrovirus. Clinical Immunology and Immunopathology 40:515–524

    Google Scholar 

  15. Redfield RR, Wright DC, Tramont EC (1986) The Walter Reed Staging Classification for HTLV III/LAV Infection. NEJM 314:131–132

    Google Scholar 

  16. Reibnegger G, Fuchs D, Hausen A, Werner ER, Dierich MP, Wachter H (1987) Theoretical implications of cellular immune reactions against helper lymphocytes infected by an immune system retrovirus. Proc Natl Acad Sci 84:7270–7274

    Google Scholar 

  17. Saag MS, Hahn BH, Gibbons J, Li Y, Parks ES, Parks WP, Shaw GM (1988) Extensive variation of human immunodeficiency virus type-1 in vivo (1988) Nature 334:440–444

    Google Scholar 

  18. Uthmann U, Geisen HP (1981) Beta-2-Mikroglobulin. DMW 106:782–786

    Google Scholar 

  19. Wachter H, Blecha HG, Fuchs D, Hausen A, Hengster P, Hinterhuber H, Reibnegger G, Reissigl H, Rössler H, Schönitzer D, Schultz T, Werner ER, Dierich MP (1986) Die Aktivierung des Makrophagen/Lymphozyten-Systems bei AIDS, ARC- und AIDS-Risikogruppen. Wiener klinische Wochenschrift: 98/14:449–454

    Google Scholar 

  20. Walker BD, Chakrabarti S, Moss B, Paradis TJ, Flynn T, Durno AG, Blumberg RS, Kaplan JC, Hirsch MS, Schooley RT (1987) HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328:345–347

    Google Scholar 

  21. De Wolf F, Goudsmit J, De Gans J, Coutinho RA, Lange JMA, Cload P, Schellekens PTA, Fiddian AP, Van der Noordaa J (1988) Effect of Zidovudine on serum Human Immunodeficiency Virus antigen levels in symptom free subjects. Lancet I:373–376

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harrer, T., Wolf, B., Kersten, W. et al. HIV-1-Antigenämie und T-Zell-Aktivierung bei HIV-1-infizierten Patienten. Klin Wochenschr 68, 864–868 (1990). https://doi.org/10.1007/BF01662783

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01662783

Key words

Navigation